Oncimmune Holdings plc
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom. Show More...
-
Website https://www.oncimmune.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.14 GBX
-
Last Updated 17-03-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-05 2011-05 2012-05 2013-05 2014-05 2015-05 2016-05 2017-05 2018-05 2019-05 TTM Earnings Per Share GBP -0.06 -0.03 -0.04 -0.24 -0.1 -0.11 -0.13 -0.16 Dividends GBP Payout Ratio % * Shares Mil 51.0 51.0 51.0 36.0 51.0 56.0 62.0 63.0 Book Value Per Share * GBP -0.07 0.15 0.11 0.15 0.03 Free Cash Flow Per Share * GBP -0.04 -0.12 -0.1 -0.12 Return on Assets % -131.85 -62.8 -90.84 -128.32 -57.03 -60.93 -67.21 -86.31 Financial Leverage (Average) 1.15 1.28 1.06 1.2 5.59 Return on Equity % -285.64 -68.18 -68.32 -74.78 -166.34 Return on Invested Capital % -210.1 -135.81 -61.79 -66.86 -75.14 -70.11 Interest Coverage -33.23 -3.55 -2.12 -11.22 -76.04 -395.38 -776.09 -111.52 Current Ratio 0.78 2.18 1.14 10.0 4.03 15.94 5.66 3.91 Quick Ratio 0.73 2.18 1.14 9.74 3.8 15.6 5.38 3.84 Debt/Equity 0.04 3.41